Iradimed (IRMD) Operating Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 21.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.78% |
| Dec 31, 2025 | -71.89% |
| Sep 30, 2025 | 18.26% |
| Jun 30, 2025 | 17.67% |
| Mar 31, 2025 | 20.89% |
| Dec 31, 2024 | 23.10% |
| Sep 30, 2024 | 23.32% |
| Jun 30, 2024 | 45.04% |
| Mar 31, 2024 | 38.77% |
| Dec 31, 2023 | 99.38% |
| Sep 30, 2023 | 95.96% |
| Jun 30, 2023 | 54.59% |
| Mar 31, 2023 | 75.82% |
| Dec 31, 2022 | 23.86% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 20.59% |
| Mar 31, 2022 | 26.64% |
| Dec 31, 2021 | 20.15% |
| Sep 30, 2021 | 28.70% |
| Jun 30, 2021 | 3.25% |
| Mar 31, 2021 | 17.79% |
| Dec 31, 2020 | -13.32% |
| Sep 30, 2020 | 58.77% |
| Jun 30, 2020 | -122.01% |
| Mar 31, 2020 | 72.05% |
| Dec 31, 2019 | 14.15% |
| Sep 30, 2019 | -0.97% |
| Jun 30, 2019 | -10.73% |
| Mar 31, 2019 | -24.24% |
| Dec 31, 2018 | -18.83% |
| Sep 30, 2018 | -23.25% |
| Jun 30, 2018 | -14.64% |
| Mar 31, 2018 | -21.69% |
| Dec 31, 2017 | 64.31% |
| Sep 30, 2017 | -21.56% |
| Jun 30, 2017 | -41.19% |
| Mar 31, 2017 | -31.79% |
| Dec 31, 2016 | 27.70% |
| Sep 30, 2016 | 93.89% |
| Jun 30, 2016 | 62.41% |